HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,442,656 | -85.3% | 162,062 | -92.0% | 0.07% | -85.7% |
| Q3 2022 | $125,378,000 | -4.2% | 2,025,821 | +23.4% | 0.50% | +2.3% |
| Q2 2022 | $130,929,000 | -32.9% | 1,641,543 | -11.5% | 0.48% | -16.8% |
| Q1 2022 | $195,045,000 | -22.4% | 1,853,863 | -20.5% | 0.58% | -14.1% |
| Q4 2021 | $251,262,000 | -26.4% | 2,331,686 | -25.2% | 0.68% | -29.5% |
| Q3 2021 | $341,476,000 | -17.0% | 3,117,368 | -29.0% | 0.96% | -25.4% |
| Q2 2021 | $411,425,000 | +7.7% | 4,393,687 | +5.9% | 1.29% | +4.4% |
| Q1 2021 | $381,892,000 | -0.6% | 4,149,195 | -21.0% | 1.24% | -3.4% |
| Q4 2020 | $384,330,000 | -15.5% | 5,253,998 | -10.2% | 1.28% | -27.8% |
| Q3 2020 | $454,678,000 | +7.4% | 5,853,222 | -23.2% | 1.77% | +2.8% |
| Q2 2020 | $423,496,000 | +71.8% | 7,619,578 | -8.4% | 1.72% | +43.8% |
| Q1 2020 | $246,437,000 | -23.1% | 8,319,945 | -6.0% | 1.20% | -6.1% |
| Q4 2019 | $320,569,000 | +41.2% | 8,855,490 | +6.2% | 1.28% | +31.5% |
| Q3 2019 | $227,110,000 | +35.7% | 8,340,441 | +19.9% | 0.97% | +38.3% |
| Q2 2019 | $167,417,000 | – | 6,958,303 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |